hypoxanthine has been researched along with Angiomyolipoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Dai, J; Du, F; Geng, R; Huang, H; Xiang, M; Xie, B | 1 |
1 other study(ies) available for hypoxanthine and Angiomyolipoma
| Article | Year |
|---|---|
Exploring serum metabolic markers for the discrimination of ccRCC from renal angiomyolipoma by metabolomics.
Topics: Adult; Aged; Angiomyolipoma; Biomarkers, Tumor; Carcinoma, Renal Cell; Chromatography, High Pressure Liquid; Creatinine; Diagnosis, Differential; Female; Humans; Hypoxanthine; Kidney Neoplasms; Male; Metabolomics; Middle Aged; Multivariate Analysis; Proton Magnetic Resonance Spectroscopy; Uric Acid; Xanthine | 2020 |